A.R.T. Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-2,996
Closed -$300K 1928
2015
Q1
$300K Sell
2,996
-5,706
-66% -$380K 0.01% 1112
2014
Q4
$456K Buy
+8,702
New +$256K 0.02% 961

A.R.T. Advisors's ASPX Position: Q2 2015 in Review

A.R.T. Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 2,996 shares — an estimated $300K sold.

A.R.T. Advisors first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $456K in Q4 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • A.R.T. Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • A.R.T. Advisors sold 2,996 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $300K.
  • A.R.T. Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • A.R.T. Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $456K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on A.R.T. Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.